The tirzepatide injection: a step-by-step guide to how it works and what to expect

Step 1: understanding what the injection delivers and why it is given this way

Tirzepatide cannot be taken as a standard oral tablet because the digestive tract would break it down before it reaches the bloodstream in meaningful concentrations. Subcutaneous injection bypasses that problem entirely, depositing the medicine into the layer of fatty tissue beneath the skin, where it is absorbed steadily over the week. That slow absorption profile is precisely why a single weekly shot produces a sustained effect on appetite and blood sugar rather than a peak-and-trough pattern.

The Mounjaro injection uses a pre-filled KwikPen, and you can find a full overview of how it works on our injectia Mounjaro page. There is no vial, no separate syringe, and nothing to mix. You attach a fresh needle, select the site, press the pen against the skin, and activate the mechanism. The needle is fine and short (designed for subcutaneous, not intramuscular, use) and most people find the sensation considerably milder than they expected. The NHS medicines page for tirzepatide describes the process clearly if you want an independent walk-through alongside this guide.

Because tirzepatide is a prescription-only medicine, a GPhC-registered prescriber reviews your health details before any pen is dispensed. That clinical step is not a formality; it is the point at which dosing, timing and any relevant interactions are considered for you specifically.

Step 2: preparing the pen and choosing your injection site

Before each injection, take the pen from the fridge and allow it to sit at room temperature for a few minutes, a cold injection into the skin is uncomfortable, and brief warming makes the process noticeably easier. Check the pen window: the liquid should be clear or slightly yellow with no particles. Attach a new needle for every injection; reusing needles blunts the tip, which increases discomfort and the risk of skin reactions. If you need a supply, compatible needles are available from our pharmacy.

Your three site options are the abdomen (at least a few centimetres from the navel), the front of the thigh, or the outer upper arm. Rotate systematically (same general area each week for a month, then move on) rather than landing repeatedly on the same small patch of skin. Cleaning the site with an alcohol swab and letting it dry before injecting is standard practice, though your Patient Information Leaflet and prescriber are the definitive guides on technique. For a detailed visual walk-through of each stage, our injection technique guide covers the process step by step.

One practical note on timing: the injection can be taken any day of the week, at any time of day. Pick a day that you can reliably repeat (some people anchor it to a Monday, or the day after payday when they know they are at home) and stick to it. Consistency helps, but a day's shift here or there will not undermine the treatment.

Step 3: the dose schedule and what to do after each injection

Treatment begins at 2.5 mg, a dose whose purpose is adjustment rather than full therapeutic effect. The prescriber will typically increase to 5 mg after four weeks, then continue in four-week steps (7.5 mg, 10 mg, 12.5 mg) up to the highest dose you tolerate well. You should not adjust the pace yourself; dose-increase decisions are made through a clinical review, and the injecting tirzepatide guide on our site explains what evidence is typically needed at each step.

After the injection, dispose of the used needle immediately in a sharps container (never in household waste) and recap the pen for storage back in the fridge. The exact room-temperature storage window is specified in the Patient Information Leaflet; always follow that rather than a general estimate. Side effects, if they appear, are most often gastrointestinal: nausea, loose stools, or a feeling of fullness that arrives quickly during meals. These are typically most noticeable in the first couple of weeks at any new dose and tend to ease as the body adjusts, according to the clinical data reviewed for NICE's appraisal of tirzepatide (TA1026).

Seek medical attention promptly for severe or persistent stomach pain that spreads toward the back, significant vomiting that prevents you keeping fluids down, or any sign of an allergic reaction. These are not common, but they warrant the same-day call, not a wait-and-see approach.

Who can use the tirzepatide injection and how to find out if it suits you

The UK licence covers adults with a BMI of 30 or above, or 27 or above when at least one weight-related condition is present, for example, high blood pressure, type 2 diabetes, high cholesterol, or obstructive sleep apnoea. Lower BMI thresholds apply for some ethnic backgrounds under UK clinical guidance. BMI alone does not determine suitability; the prescriber looks at your full health picture, current medicines, and relevant history. You can read more about how tirzepatide is used for weight management on our tirzepatide injection uses page.

For those considering private treatment, a useful starting point is the cost context available on our weight-loss treatment overview, which sets out what a private prescription realistically involves. The injection is not recommended during pregnancy, while breastfeeding, or when actively trying to conceive. It is not licensed for under-18s. If you take an oral contraceptive pill, your prescriber will advise adding a barrier method for the first four weeks of treatment and for four weeks after each dose increase, because tirzepatide slows gastric emptying in a way that may reduce pill absorption.

If you think the tirzepatide injection could be right for you, speaking to our prescribers is a straightforward next step. The consultation is free, carried out by a GPhC-registered prescriber who reads every submission personally, and there is no obligation to proceed. Speak to our prescribers and find out whether this treatment fits your circumstances.